Session #1: COVID-19 vaccine update
Tuesday, February 23, 2021
Presenters:
- Robert L. Alesiani, PharmD, BCGP, Chief Pharmacotherapy Officer, Tabula Rasa HealthCare (TRHC).
- Ankur Patel, MD, MBA, FAAFP, Chief Medical Director, TRHC
Session #2: ACE2, ACE, ARBs, and prescribing habits in connection to the COVID-19 pandemic
Wednesday, March 10, 2021
Presenters:
- Veronique Michaud, BPharm, MSc, PhD Chief Operating Officer, TRHC Precision Pharmacotherapy Research & Development Institute
- Jenny Bingham, PharmD, BCACP, CMWA Director, Ambulatory Care Residency Programs & Research, Scientific Research & Education, TRHC
Session #3: COVID-19 Repurposed Drugs—What are the Risks?
Wednesday, March 24, 2021
Presenters:
- Jacques Turgeon, BPharm, PhD, Chief Scientific Officer, TRHC/Chief Executive Officer, Precision Pharmacotherapy Research & Development Institute.
- Robert L. Alesiani, PharmD, BCGP, Chief Pharmacotherapy Officer, TRHC
Session #4: Simulation Studies and Outcomes
Wednesday, April 21, 2021, 12 p.m. ET
Presenters:
- Veronique Michaud, BPharm, MSc, PhD, Chief Operating Officer, Tabula Rasa HealthCare (TRHC) Precision Pharmacotherapy Research & Development Institute.
- Matt Smith, PhD, Research Data Scientist, Tabula Rasa HealthCare Precision Pharmacotherapy Research & Development Institute